We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+8.75%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$3.69B
AUM Growth
+$319M
(+9.5%)
Cap. Flow
+$89M
Cap. Flow
% of AUM
2.41%
Top 10 Holdings %
Top 10 Hldgs %
34.5%
Holding
3,484
New
163
Increased
1,467
Reduced
807
Closed
181
Avg Time Held Equity + Options
4.2
years
Top 10 Avg Time Held Equity + Options
1.9
years
Top 20 Avg Time Held Equity + Options
3
years
Avg Time Held Equity only
4.2
years
Top 10 Avg Time Held Equity only
1.9
years
Top 20 Avg Time Held Equity only
3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$50.7M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$21.6M |
| 3 |
Janus Henderson Mortgage-Backed Securities ETF
JMBS
|
+$15.3M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$7.94M |
| 5 |
Apple
AAPL
|
+$4.05M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$43.6M |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$32.8M |
| 3 |
iShares MSCI Emerging Markets ex China ETF
EMXC
|
+$3.62M |
| 4 |
NVIDIA
NVDA
|
+$1.54M |
| 5 |
Schwab US Dividend Equity ETF
SCHD
|
+$1.39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 48.78% |
| 2 | Technology | 15.28% |
| 3 | Healthcare | 8.29% |
| 4 | Financials | 6.97% |
| 5 | Communication Services | 4.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3076
LendingTree
TREE
$363M
| $423 | ﹤0.01% |
10
| – | – |
2020 Q1
16 quarters
|
|
3077
Thryv Holdings
THRY
$53.8M
| $422 | ﹤0.01% |
19
| – | – |
2023 Q4
1 quarter
|
|
3078
National Vision
EYE
$1.4B
| $421 | ﹤0.01% |
19
-22
| -54% | -$464 |
2023 Q2
3 quarters
|
|
3079
Microvision
MVIS
$37.6M
| $418 | ﹤0.01% |
15
+4
| +36% | +$136 |
2023 Q3
2 quarters
|
|
3080
Boston Omaha
BOC
$384M
| $417 | ﹤0.01% |
27
| – | – |
2023 Q3
2 quarters
|
|
3081
Cornerstone Strategic Value Fund
CLM
$1.96B
| $414 | ﹤0.01% |
56
| – | – |
2019 Q2
19 quarters
|
|
3082
1-800-Flowers.com
FLWS
$184M
| $412 | ﹤0.01% |
38
| – | – |
2020 Q2
15 quarters
|
|
3083
Supernus Pharmaceuticals
SUPN
$2.3B
| $409 | ﹤0.01% |
12
| – | – |
2022 Q3
6 quarters
|
|
3084
Altimmune
ALT
$459M
| $407 | ﹤0.01% |
40
| – | – |
2021 Q1
12 quarters
|
|
3085
DELISTED
Cassava Sciences, Inc. Warrant
SAVAW
| $407 | ﹤0.01% |
+101
| New | +$603 |
2024 Q1
0 quarters
|
|
3086
DoubleLine Yield Opportunities Fund
DLY
$636M
| $397 | ﹤0.01% |
25
+1
| +4% | +$15 |
2021 Q4
9 quarters
|
|
3087
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $384 | ﹤0.01% |
170
-164
| -49% | -$360 |
2022 Q3
6 quarters
|
|
3088
Outdoor Holding Co
POWW
$250M
| $380 | ﹤0.01% |
138
| – | – |
2022 Q4
5 quarters
|
|
3089
Marcus & Millichap
MMI
$1.07B
| $376 | ﹤0.01% |
11
| – | – |
2023 Q4
1 quarter
|
|
3090
3D Systems Corp
DDD
$492M
| $373 | ﹤0.01% |
84
| – | – |
2016 Q4
29 quarters
|
|
3091
DELISTED
Endeavor Group Holdings, Inc.
EDR
| $360 | ﹤0.01% |
14
| – | – |
2023 Q4
1 quarter
|
|
3092
Vanda Pharmaceuticals
VNDA
$256M
| $358 | ﹤0.01% |
+87
| New | +$348 |
2024 Q1
0 quarters
|
|
3093
Under Armour Class C
UA
$2.04B
| $357 | ﹤0.01% |
50
+17
| +52% | +$130 |
2016 Q4
29 quarters
|
|
3094
DELISTED
Agiliti Inc
AGTI
| $344 | ﹤0.01% |
34
| – | – |
2023 Q4
1 quarter
|
|
3095
Intapp
INTA
$3.35B
| $343 | ﹤0.01% |
10
-23
| -70% | -$904 |
2022 Q4
5 quarters
|
|
3096
Liberty Latin America Class A
LILA
$1.62B
| $342 | ﹤0.01% |
72
| – | – |
2021 Q4
9 quarters
|
|
3097
Brown-Forman Class A
BF.A
$13.4B
| $337 | ﹤0.01% |
6
| – | – |
2020 Q2
15 quarters
|
|
|
IRLA
3098
IRulya Therapeutics Inc. Common Stock
IRLA
$33.8M
| $330 | ﹤0.01% |
2
-10
| -83% | -$2.48K |
2020 Q1
16 quarters
|
|
3099
Byline Bancorp
BY
$1.67B
| $326 | ﹤0.01% |
+15
| New | +$323 |
2024 Q1
0 quarters
|
|
3100
Kymera Therapeutics
KYMR
$8.99B
| $322 | ﹤0.01% |
8
| – | – |
2023 Q4
1 quarter
|
|
Similar funds
Parallel Advisors's Q1 2024 Portfolio in Review
As of Q1 2024, Parallel Advisors held 3,484 positions worth $3.69B, up 9.5% from $3.37B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Parallel Advisors's Q1 2024 filing shows 163 new, 1,467 increased, 807 reduced and 181 closed positions. Its largest new stake was Janus Henderson Mortgage-Backed Securities ETF: 338,790 shares worth $15.3M. The largest sale was iShares Core S&P Total US Stock Market ETF, an estimated $43.6M.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 49% a quarter earlier, followed by Technology and Healthcare.
- Parallel Advisors's largest Q1 2024 buy was Janus Henderson Mortgage-Backed Securities ETF: 338,790 shares worth $15.3M.
- Parallel Advisors added most to Invesco S&P 500 Equal Weight ETF in Q1 2024, an estimated $50.7M increase.
- Parallel Advisors's biggest Q1 2024 reduction was iShares Core S&P Total US Stock Market ETF, cutting an estimated $43.6M.
- Parallel Advisors fully exited Lions Gate Entertainment Corp. Class B Non-Voting Shares in Q1 2024, selling an estimated $335K.
- Parallel Advisors's ten largest holdings make up 35% of its $3.69B portfolio in Q1 2024.
- Parallel Advisors opened 163 new positions and closed 181 in Q1 2024.
- Parallel Advisors's portfolio value rose 9.5% quarter-over-quarter to $3.69B.
Based on Parallel Advisors's 13F filing for Q1 2024, filed 6 May 2024.